Cargando…
Coronavirus Disease 2019 and Primary Antibody Deficiencies. Comment on Milota et al. Clinical Outcome of Coronavirus Disease 2019 in Patients with Primary Antibody Deficiencies. Pathogens 2023, 12, 109
Autor principal: | Özdemir, Öner |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10146560/ https://www.ncbi.nlm.nih.gov/pubmed/37111418 http://dx.doi.org/10.3390/pathogens12040532 |
Ejemplares similares
-
Clinical Outcome of Coronavirus Disease 2019 in Patients with Primary Antibody Deficiencies
por: Milota, Tomas, et al.
Publicado: (2023) -
Allergic Disease with Selective IgA Deficiency. Comment on Cinicola et al. The Allergic Phenotype of Children and Adolescents with Selective IgA Deficiency: A Longitudinal Monocentric Study. J. Clin. Med. 2022, 11, 5705
por: Özdemir, Öner
Publicado: (2023) -
Severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Combination Therapy in Patients With Coronavirus Disease 2019 and Primary Antibody Deficiency
por: Pulvirenti, Federica, et al.
Publicado: (2021) -
Likelihood of survival of coronavirus disease 2019
por: Ruan, Shigui
Publicado: (2020) -
Asthma and prognosis of coronavirus disease 2019
por: Özdemir, Öner
Publicado: (2022)